Booming U.S. Biotech Could Buckle Next in China Trade Tango
Increasing wariness in Washington over China's investments in U.S. biotechnology companies may cool a hot source of capital for medical startups. Chinese investors have been a mainstay of recent fundraising by private biotechnology firms.
from Biotech News
0 Comments